| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/24/2002 | WO2002006502A2 Adenovirus vectors comprising introns |
| 01/24/2002 | WO2002006453A2 Regulation of human desc1-like serine protease |
| 01/24/2002 | WO2002005866A2 Deployment system for myocardial cellular material |
| 01/24/2002 | WO2002005864A1 An implantable or insertable therapeutic agent delivery device |
| 01/24/2002 | WO2002005847A1 Kubouchi's method of intramuscularly injecting mixture of drug with patient's blood and kubouchi's substances produced thereby |
| 01/24/2002 | WO2002005840A1 Medicinal compositions for promoting fixation of transplanted cells |
| 01/24/2002 | WO2002005829A2 Methods and formultations with probiotic microorganisms and medicaments |
| 01/24/2002 | WO2002005828A1 Compositions and methods for the treatment of skin damage |
| 01/24/2002 | WO2001076360A3 Synchronization of the cytoplasmatic and the nuclear maturation of oocytes in vitro |
| 01/24/2002 | WO2001070767A3 Therapeutic anti-melanoma compounds |
| 01/24/2002 | WO2001064750A3 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 01/24/2002 | WO2001062239A3 Novel compositions and uses of dictyostatin compounds |
| 01/24/2002 | WO2001059073A3 Cytotoxic t lymphocytes activated by dendritic cell hybrids |
| 01/24/2002 | WO2001056405A3 A method for maintaining or improving the synthesis of mucins |
| 01/24/2002 | WO2001055212A3 Delivery of therapeutic biological from implantable tissue matrices |
| 01/24/2002 | WO2001053324A3 Novel haptotactic peptides |
| 01/24/2002 | WO2001052878A3 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 01/24/2002 | WO2001039797A3 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 01/24/2002 | WO2001025397A3 Compositions and methods for tumor-targeted delivery of effector molecules |
| 01/24/2002 | WO2001008708A3 Enhanced delivery via serpin enzyme complex receptor ligands |
| 01/24/2002 | WO2000073478A9 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| 01/24/2002 | WO2000073338A9 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 01/24/2002 | US20020010949 Cloning using donor nuclei from differentiated fetal and adult cells |
| 01/24/2002 | US20020010948 Swine defective for transmission of porcine endogenous retrovirus and uses thereof |
| 01/24/2002 | US20020010208 Dha-pharmaceutical agent conjugates of taxanes |
| 01/24/2002 | US20020010146 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 01/24/2002 | US20020010138 Treatment of neuromuscular disorders and conditions with different botulinum |
| 01/24/2002 | US20020009806 Apparatus for propagation of preferential cells and detection of cell propagation modulators |
| 01/24/2002 | US20020009805 Support for the propagation of preferential tissues |
| 01/24/2002 | US20020009800 Genetically engineeered sequences for use in gene therapy of central nervous system |
| 01/24/2002 | US20020009783 Aqueous solutions comprising a polysaccharide oncotic agent, a physiologically compatible buffer, a simple hexose sugar, dissolved chloride salt of sodium, calcium and magnesium and an organic acid or salt or ester, substitute for blood |
| 01/24/2002 | US20020009776 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/24/2002 | US20020009743 That proliferate in an in vitro culture, obtained by differentiating primate pluripotent stem (pPS) cells, where certain proportion of cells are committed to form neuronal cells, glial cells, or both; screening compounds |
| 01/24/2002 | US20020009726 CD40 associated proteins |
| 01/24/2002 | US20020009706 Method for loading cells with an agent |
| 01/24/2002 | US20020009501 Preparation of cartilage extracts using organic solvents |
| 01/24/2002 | US20020009500 Therapeutic platelets and methods |
| 01/24/2002 | US20020009499 Obtained by heating and burning surf clam shells in a nitrogen atmosphere |
| 01/24/2002 | US20020009481 Substance with antiobese and cumulative visceral fat-reducing actions and use thereof |
| 01/24/2002 | US20020009461 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 01/24/2002 | US20020009456 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 01/24/2002 | US20020009455 Prostate glands; diagnosis, therapy |
| 01/24/2002 | US20020009448 Immunology therapy |
| 01/24/2002 | US20020009438 Antimicrobial agents isolated from aloe vera |
| 01/24/2002 | US20020009431 Method for transplanting cells into the brain and therapeutic uses therefor |
| 01/24/2002 | US20020009430 Isolation of tumor cells; incubation |
| 01/24/2002 | US20020008210 Apparatus for the irradiation of a liquid |
| 01/24/2002 | DE10031851A1 Photodynamische Behandlung und UV-B-Bestrahlung einer Thrombozyten-Suspension Photodynamic treatment and UV-B irradiation of a platelet suspension |
| 01/24/2002 | CA2416120A1 Methods and formulations with probiotic microorganisms and medicaments |
| 01/24/2002 | CA2415701A1 Compositions and methods for the treatment of skin damage |
| 01/24/2002 | CA2415347A1 Adenovirus vectors comprising introns |
| 01/24/2002 | CA2415128A1 An implantable or insertable therapeutic agent delivery device |
| 01/23/2002 | EP1174142A2 Immunopotentiator comprising peptide and hyaluronic acid |
| 01/23/2002 | EP1173597A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors |
| 01/23/2002 | EP1173573A1 Method for down-regulating il5 activity |
| 01/23/2002 | EP1173571A2 Human ion channel proteins |
| 01/23/2002 | EP1173568A2 Laminin 2 and methods for its use |
| 01/23/2002 | EP1173564A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension |
| 01/23/2002 | EP1173560A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2002 | EP1173556A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such |
| 01/23/2002 | EP1173550A1 Method for diminishing specific immune reactions |
| 01/23/2002 | EP1173549A2 Use of cytokines and mitogens to inhibit pathological immune responses |
| 01/23/2002 | EP1173548A2 Materials and methods relating to neuronal development |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173475A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 01/23/2002 | EP1173204A1 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/23/2002 | EP1017789A4 Nucleic acid encoding a lectin-derived progenitor cell preservation factor |
| 01/23/2002 | EP0941103B1 Pharmaceutical composition for treatment of diabetes |
| 01/23/2002 | EP0755258B1 Methods of treating disease using sertoli cells and allografts or xenografts |
| 01/23/2002 | EP0696205B1 Use of neuro-derived fetal cell lines for transplantation therapy |
| 01/23/2002 | CN1332801A Connective tissue growth factor (CTGF) and methods of use |
| 01/23/2002 | CN1332799A Cancer cell vaccine |
| 01/23/2002 | CN1332646A Method for production of stroma-free hemoglobin |
| 01/23/2002 | CN1332631A Composition and method for increasing weight gain and feed efficiency |
| 01/23/2002 | CN1332011A Medicine for treating psoriasis, ichthyosis and eczema |
| 01/23/2002 | CN1332010A Chinese medicine prepn for treating psychosis |
| 01/23/2002 | CN1332007A Powerful pain-stopping aerosol |
| 01/23/2002 | CN1332001A Tonic medicine for phthisis patient and its prepn |
| 01/23/2002 | CN1331996A Hepatitis B treaitng pill |
| 01/23/2002 | CN1331995A Chinese medicine composition for treating lung cancer |
| 01/23/2002 | CN1331994A Chinese medicine for treating diabetic neural lesion |
| 01/23/2002 | CN1331993A Hypoglycemic deep-rooted ulcer eliminating medicine |
| 01/23/2002 | CN1331991A Chinese medicine bolus for treating cataract |
| 01/23/2002 | CN1331990A Chinese medicine for treating diabetes |
| 01/23/2002 | CN1331989A Chinese medicine for treating thromboangitis obliterans |
| 01/23/2002 | CN1331988A Stone expelling medicine powder |
| 01/23/2002 | CN1331984A External-use trauma treating ointment |
| 01/23/2002 | CN1331983A Hyperosteogeny treating medicine |
| 01/23/2002 | CN1331977A Chinese medicine powder for treating rheumatoid arthritis |
| 01/23/2002 | CN1331976A Traumtin prepn for injecta and its prepn process |
| 01/23/2002 | CN1078248C Insulin-secreting cell lines, methods of production and use |
| 01/23/2002 | CN1078083C Bone-calcium liquid protein and its preparation method |
| 01/23/2002 | CN1078081C Medicine for treating osteoproliferation, rheumatism and rheumatoid arthitis, and preparing method thereof |
| 01/23/2002 | CN1078078C Traditional Chinese medicinal preparation for curing endometriosis |
| 01/23/2002 | CN1078077C Non-scar neutral burn ointment and its prep. |
| 01/22/2002 | US6340673 Administering at or near a site of a tumor of tumorigenic disease a herpes simplex virus vector lacking an expressible .gamma..sub.1 34.5 gene, whereby the growth of tumor is suppressed |
| 01/22/2002 | US6340667 Contacting the bacteria or fungi with a bacterial of fungal cell killing effective amount of a fragment of reptilian hemoglobin protein, selected from reptilian heme-free hemoglobin .alpha. chain, a reptilia heme-free hemoglobin |
| 01/22/2002 | US6340477 Bone matrix composition and methods for making and using same |
| 01/22/2002 | US6340457 Pharmaceutical and alimentary compositions containing bacteria of genus acetobacter |
| 01/17/2002 | WO2002004623A2 ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE |